$1.36
-0.02 (-1.45%)
Open$1.38
Previous Close$1.38
Day High$1.39
Day Low$1.36
52W High$3.09
52W Low$1.53
Volume—
Avg Volume118.2K
Market Cap259.04M
P/E Ratio14.26
EPS$0.13
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,816.9% upside
Current
$1.36
$1.36
Target
$39.67
$39.67
$29.46
$39.67 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 386.66M | 319.18M | 81.33M |
| Net Income | -36,932,382 | -27,438,619 | 15.27M |
| Profit Margin | -9.6% | -9.1% | 18.8% |
| EBITDA | -6,685,542 | -5,242,913 | 21.57M |
| Free Cash Flow | — | — | 16.42M |
| Rev Growth | +21.1% | +21.1% | -3.5% |
| Debt/Equity | 0.22 | 0.22 | 0.20 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |